z-logo
Premium
Evaluation of salivary heme oxygenase‐1 as a potential biomarker of early Parkinson's disease
Author(s) -
Song Wei,
Kothari Vimal,
Velly Ana M.,
Cressatti Marisa,
Liberman Adrienne,
Gornitsky Mervyn,
Schipper Hyman M.
Publication year - 2018
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.27328
Subject(s) - heme oxygenase , biomarker , heme , saliva , pathogenesis , oxygenase , medicine , western blot , oxidative stress , endocrinology , chemistry , biochemistry , enzyme , gene
Background and Hypothesis To date, there are no chemical analytes, including biochemical indices of oxidative stress, metabolites of α‐synuclein protein, and differential protein expression patterns on proteomic profiling, for use in clinics as a diagnostic biomarker of idiopathic PD. Objectives Heme oxygenase‐1 has been implicated in the pathogenesis of PD. The objective of this study is to ascertain whether salivary heme oxygenase‐1 may serve as a biomarker for early idiopathic PD. Methods Fifty‐eight PD patients and 59 non‐neurological disease controls were recruited. Levels of heme oxygenase‐1 expression were assayed using enzyme‐linked immunosorbent assay and western blot analysis of whole, unstimulated saliva. Analyses were adjusted by sex, l ‐dopa exposure, and relevant comorbidities. Results We documented: (1) the presence of 32‐kDa heme oxygenase‐1 protein in human saliva; (2) significantly higher mean heme oxygenase‐1 protein concentrations in saliva of PD patients relative to control values; (3) no variability in salivary heme oxygenase‐1 levels with sex, age, l ‐dopa equivalence, or comorbidities; and (4) significantly higher mean salivary heme oxygenase‐1 concentrations in patients with H & Y stage 1 PD (early) than control subjects and stage 2 and stage 3 PD patients. The area under the receiver operating characteristic curve that separated controls from PD H & Y stage 1 was 76% (95% confidence interval: 63‐90). Conclusions Salivary heme oxygenase‐1 concentrations may provide a useful, noninvasive, and relatively inexpensive biomarker of early idiopathic PD. © 2018 International Parkinson and Movement Disorder Society

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here